Clinical and causality assessment in herbal hepatotoxicity

Bibliography

• Reuben A, Koch DG, Lee WM; Acute Liver Failure Study Group. Drug-induced acute liver failure: results of a U.S. multicenter, prospective study. Hepatology 2010;52:2065-76
   PubMed Web of Science ®Google Scholar
• Andrade RJ, Camargo R, Lucena MI, Causality assessment in drug-induced hepatotoxicity. Expert Opin Drug Saf 2004;3:329-44
   PubMedGoogle Scholar
• Agarwal VK, McHutchison JG, Hoofnagle JH; Drug-Induced Liver Injury Network (DILIN). Important elements for the diagnosis of drug-induced liver injury. Clin Gastroenterol Hepatol 2010;8:463-70
   PubMed Web of Science ®Google Scholar
• Chalasani N, Björnsson E. Risk factors for idiosyncratic drug-induced liver injury. Gastroenterology 2010;138:2246-59
   PubMed Web of Science ®Google Scholar
• Estes JD, Stolpman D, Olyaei A, High prevalence of potentially hepatotoxic herbal supplement use in patients with fulminant hepatic failure. Arch Surg 2003;138:852-8
   PubMed Web of Science ®Google Scholar
• Seeff KB. Herbal hepatotoxicity. Clin Liv Dis 2007;11:577-96
   PubMedGoogle Scholar
• Navarro VJ. Herbal and dietary supplement hepatotoxicity. Semin Liver Dis 2009;29:373-82
   PubMed Web of Science ®Google Scholar
• Teschke R, Wolff A, Frenzel C, Herbal hepatotoxicity: a tabular compilation of reported cases. Liver Int 2012;32:1543-56
   PubMed Web of Science ®Google Scholar
• Teschke R, Frenzel C, Glass X, Herbal hepatotoxicity: a critical review. Br J Clin Pharmacol 2013;75:630-6
   PubMed Web of Science ®Google Scholar
• Bower WA, Johns M, Margolis HS, Population-based surveillance for acute liver failure. Am J Gastroenterol 2007;102:2459-63
   PubMed Web of Science ®Google Scholar
• Sgro C, Clinard F, Ouazir K, Incidence of drug-induced hepatic injuries: A French population-based study. Hepatology 2002;36:451-5
   PubMed Web of Science ®Google Scholar
• Navarro VJ, Senior JR. Drug-related hepatotoxicity. NEJM 2006;354:73-739
   Google Scholar
• De Abajo FJ, Montero D, Madurga M, Acute and clinically relevant drug-induced liver injury: a population based case-control study. Br J Clin Pharmacol 2004;58:71-80
   PubMed Web of Science ®Google Scholar
• Chalasani N, Fontana RJ, Bonkovsky HL, For the Drug Induced Liver Injury Network (DILIN). Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology 2008;135:1924-34
   PubMed Web of Science ®Google Scholar
• Blumenthal M, Lindstrom A, Ooyen C, Herb supplement sales increase 4.5% in 2011. HerbalGram 2012;95:60-4
   Google Scholar
• WHO. Guideline on good agricultural and collection practices (GACP) for medicinal plants. Geneva, WHO, 2003. Available from: http://whqlibdoc.who.int/publications/2003/9241546271.pdf [Accessed 3 September 2012]
   Google Scholar
• WHO. Technical Report Series, No. 937, 2006. Annex 3. Supplementary guidelines on good manufacturing practices for the manufacture of herbal medicines. Available from: http://infocollections.org/medregpack/documents/d0099/d0099.pdf [Accessed 3 September 2012]
   Google Scholar
• WHO. Guidelines for assessing quality of herbal medicines with reference to contaminants and residues. 2007. Available from: http://apps.who.int/medicinedocs/documents/s14878e/s14878e.pdf [Accessed 3 September 2012]
   Google Scholar
• Teschke R, Lebot V. Proposal for a Kava Quality Standardization Code. Food Chem Toxicol 2011;49:2503-16
   PubMed Web of Science ®Google Scholar
• Lebot V. The quality of kava consumed in the South Pacific. HerbalGram 2006;71:34-7
   Google Scholar
• Schmidt M. Quality criteria for kava. HerbalGram 2007;73:45-9
   Google Scholar
• Teschke R, Qiu SX, Xuan TD, Kava and kava hepatotoxicity: requirements for novel experimental, ethnobotanical, and clinical studies based on a review of the evidence. Phytother Res 2011;25:1262-74
   Web of Science ®Google Scholar
• BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte, Bonn. Federal Institute for Drugs and Medicinal Products in Germany). Rejection of Drug Risks, Step II. As related to: Kava-Kava (Piper methysticum)-containing, and kavain-containing drugs, including homeopathic preparations with a final concentration up to, and including D4. June 14, 2002. Available from: http://www.spc.int/cis/documents/02_0714_BfArM_Kava_Removal.pdf [Accessed 3 September 2012]
   Google Scholar
• Teschke R, Schwarzenboeck A, Hennermann KH. Kava hepatotoxicity: a clinical survey and critical analysis of 26 suspected cases. Eur J Gastroenterol Hepatol 2008;20:1182-93
   PubMed Web of Science ®Google Scholar
• Teschke R. Kava hepatotoxicity – a clinical review. Ann Hepatol 2010;9:251-65
   PubMed Web of Science ®Google Scholar
• Teschke R, Sarris J, Lebot V. Kava hepatotoxicity solution: a six-point plan for new kava standardization. Phytomedicine 2011;18:96-103
   PubMed Web of Science ®Google Scholar
• Teschke R. Kava hepatotoxicity: pathogenetic aspects and prospective considerations. Liver Int 2010;30:1270-9
   PubMed Web of Science ®Google Scholar
• WHO (World Health Organization). Assessments of the risk of hepatotoxicity with kava products. WHO Document Production Services, Geneva, Switzerland; 2007
   Google Scholar
• Mahady GB, Low Dog T, Barrett ML, United States Pharmacopeia review of the black cohosh case reports of hepatotoxicity. Menopause 2008;15:628-38
   PubMed Web of Science ®Google Scholar
• EMA: assessment of case reports connected to herbal medicinal products containing cimicifugae racemosae rhizoma (black cohosh, root). Issued May 8, 2007. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Herbal_-_HMPC_assessment_report/2010/02/WC500074167.pdf [Accessed 3 September 2012]
   Google Scholar
• Teschke R. Black cohosh and suspected hepatotoxicity - inconsistencies, confounding variables, and prospective use of a diagnostic causality algorithm: a critical review. Menopause 2010;17:426-40
   PubMed Web of Science ®Google Scholar
• Teschke R, Schmidt-Taenzer W, Wolff A. Spontaneous reports of assumed herbal hepatotoxicity by black cohosh: is the liver unspecific Naranjo scale precise enough to ascertain causality? Pharmacoepidemiol Drug Saf 2011;20:567-82
   PubMed Web of Science ®Google Scholar
• Teschke R, Schwarzenboeck A, Schmidt-Taenzer W, Herb induced liver injury presumably caused by black cohosh: a survey of initially purported cases and herbal quality specifications. Ann Hepatol 2011;11:249-59
   Google Scholar
• Teschke R, Glass X, Schulze J. Herbal hepatotoxicity by Greater Celandine (Chelidonium majus): causality assessment of 22 spontaneous reports. Regul Toxicol Pharmacol 2011;61:282-91
   PubMed Web of Science ®Google Scholar
• Teschke R, Glass X, Schulze J, Suspected Greater Celandine hepatotoxicity: liver specific causality evaluation of published case reports from Europe. Eur J Gastroenterol Hepatol 2012;24:270-80
   PubMed Web of Science ®Google Scholar
• Teschke R, Frenzel C, Glass X, Greater Celandine hepatotoxicity: a clinical review. Ann Hepatol 2012;11:838-48
   PubMed Web of Science ®Google Scholar
• Teschke R, Frenzel C, Schulze J, Spontaneous reports of primarily suspected herbal hepatotoxicity by Pelargonium sidoides: was causality adequately ascertained? Regul Toxicol Pharmacol 2012;63:1-9
   PubMed Web of Science ®Google Scholar
• Teschke R, Frenzel C, Wolff A, Initially purported hepatotoxicity by Pelargonium sidoides: the dilemma of pharmacovigilance and proposals for improvements. Ann Hepatol 2012;11:500-12
   PubMed Web of Science ®Google Scholar
• Teschke R, Schulze J. Risk of kava hepatotoxicity and the FDA consumer advisory. J Am Med Ass 2010;304:2174-5
   Web of Science ®Google Scholar
• Sarris J, Kavanagh DJ, Byrne G, The Kava Anxiety Depression Spectrum Study (KADSS): a randomized, placebo-controlled crossover trial using an aqueous extract of Piper methysticum. Psychopharmacology (Berl) 2009;205:399-407
   PubMed Web of Science ®Google Scholar
• Health Canada. Black cohosh products and liver toxicity: update. Canadian Adverse Reaction Newsletter 2010;20:1-3. Available from: http://www.hc-sc.gc.ca/dhp-mps/medeff/bulletin/carn-bcei_v20n1-eng.php#a1t1 [ [Accessed 3 September 2012]
   Google Scholar
• Ko RJ. Adulterants in Asian patent medicines. N Engl J Med 1998;339:847
   PubMed Web of Science ®Google Scholar
• Huang WF, Wen KC, Hsiao ML. Adulteration by synthetic therapeutic substances of traditional Chinese medicines in Taiwan. J Clin Pharmacol 1997;37:344-50
   PubMed Web of Science ®Google Scholar
• Espinoza EO, Mann MJ, Bleasdell B. Arsenic and mercury in traditional Chinese herbal balls. N Engl J Med 1995;333:803-4
   PubMed Web of Science ®Google Scholar
• Gertner E, Marshall PS, Filandrinos D, Complications resulting from the use of Chinese herbal medications containing undeclared prescription drugs. Arthritis Rheum 1995;38:614-17
   PubMed Web of Science ®Google Scholar
• Kang-Yum E, Oransky SH. Chinese patent medicine as a potential source of mercury poisoning. Vet Hum Toxicol 1992;34:235-8
   PubMedGoogle Scholar
• Teschke R, Sarris J, Lebot V. Contaminant hepatotoxins as culprits for kava hepatotoxicity – fact or fiction? Phytother Res 2013; DOI: 10.1002/ptr.4729
   Web of Science ®Google Scholar
• Batchelor WB, Heathcote J, Wanless IR. Chaparral-induced hepatic injury. Am J Gastroenterol 1995;90:831-3
   PubMed Web of Science ®Google Scholar
• Perharic-Walton L, Murray V. Toxicity of traditional Chinese herbal remedies. Lancet 1992;340:674
   PubMed Web of Science ®Google Scholar
• Davies EG, Pollock I, Steel HM. Chinese herbs for eczema. Lancet 1990;336:117
   Google Scholar
• Kane JA, Kane SP, Jain S. Hepatitis induced by traditional Chinese herbs; possible toxic components. Gut 1995;36:146-7
   PubMed Web of Science ®Google Scholar
• Horowitz RS, Feldhaus K, Dart RC, The clinical spectrum of Jin Bu Huang toxicity. Arch Intern Med 1996;156:899-903
   PubMed Web of Science ®Google Scholar
• Woolf GM, Petrovic LM, Rojter SE, Acute hepatitis associated with the Chinese herbal product Jin Bu Huan. Ann Intern Med 1994;121:729-35
   PubMed Web of Science ®Google Scholar
• Nadir A, Agrawal S, King PD, Acute hepatitis associated with the use of a Chinese herbal product, Ma-huang. Am J Gastroentol 1996;91:1436-8
   PubMed Web of Science ®Google Scholar
• Itoh S, Marutani K, Nishijima T, Liver injuries induced by herbal medicine, Syo-saiko-to (xiao-chai-hu-tang). Dig Dis Sci 1995;40:1845-8
   PubMed Web of Science ®Google Scholar
• Larrey D, Vial T, Pauwels A, Hepatitis after Germander (Teucrium chamaedrys) administration: another instance of herbal medicine hepatotoxicity. Ann Intern Med 1992;117:129-32
   PubMed Web of Science ®Google Scholar
• Laliberté L, Villeneuve JP. Hepatitis after the use of Germander, a herbal remedy. Can Med Assoc J 1996;154:1689-92
   PubMed Web of Science ®Google Scholar
• Strahl S, Ehret V, Dahm HH, Necrotising hepatitis after taking herbal remedies. Dtsch Med Wschr 1998;123:1410-14; Article in German
   PubMed Web of Science ®Google Scholar
• Benninger J, Schneider HT, Schuppan D, Acute hepatitis induced by Greater Celandine (Chelidonium majus). Gastroenterology 1999;117:1234-7
   PubMed Web of Science ®Google Scholar
• Stickel F, Pöschl G, Seitz HK, Acute hepatitis induced by Greater Celandine (Chelidonium majus). Scand J Gastroenterol 2003;38:565-8
   PubMed Web of Science ®Google Scholar
• Elinav E, Pinkser G, Safadi R, Association between consumption of Herbalife® nutritional supplements and acute hepatotoxicity. J Hepatol 2007;47:514-20
   PubMed Web of Science ®Google Scholar
• Schoepfer AM, Engel A, Fattinger K, Herbal does not mean innocuous: ten cases of severe hepatotoxicity associated with dietary supplements from Herbalife® products. J Hepatol 2007;47:521-6
   PubMed Web of Science ®Google Scholar
• Harvey J, Colin-Jones DG. Mistletoe hepatitis. Br Med J 1981;282:186-7
   PubMed Web of Science ®Google Scholar
• Beuers U, Spengler U, Pape GR. Hepatitis after chronic abuse of senna. Lancet 1991;337:372-3
   PubMed Web of Science ®Google Scholar
• Yang L, Aronsohn A, Hart J, Herbal hepatotoxicity from Chinese skullcap: a case report. World J Hepatol 2012;4(7):231-3
   PubMedGoogle Scholar
• Danan G, Bénichou C; Causality assessment of adverse reactions to drugs – I. A novel method based on the conclusions of International Consensus Meetings: application to drug-induced liver injuries. J Clin Epidemiol 1993;46:1323-30
   PubMed Web of Science ®Google Scholar
• Bénichou C, Danan G, Flahault A. Causality assessment of adverse reactions to drugs – II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge. J Clin Epidemiol 1993;46:1331-6
   PubMed Web of Science ®Google Scholar
• Teschke R, Schwarzenboeck A, Hennermann KH. Causality assessment in hepatotoxicity by drugs and dietary supplements. Br J Clin Pharmacol 2008;66:758-66
   PubMed Web of Science ®Google Scholar
• Liss G, Lewis JH. Drug-induced liver injury: what was new in 2008? Expert Opin Drug Metab Toxicol 2009;5:843-60
   PubMed Web of Science ®Google Scholar
• Björnsson E, Jacobsen EI, Kalaitzakis E. Hepatotoxicity associated with statins: reports of idiosyncratic liver injury post-marketing. J Hepatol 2012;56:374-80
   PubMed Web of Science ®Google Scholar
• Teschke R, Frenzel C, Wolff A, Rare statin hepatotoxicity: convincing evidence based on breakthrough case study. J Hepatol 2012;57:699-700
   PubMed Web of Science ®Google Scholar
• Ramachandran R, Kakar S. Histological patterns in drug-induced liver disease. J Clin Pathol 2009;62:481-92
   PubMed Web of Science ®Google Scholar
• Dunbar K, Solga SF. Black cohosh, safety, and public awareness. Liver Int 2007;27:1017-18
   PubMed Web of Science ®Google Scholar
• Teschke R, Schwarzenboeck A. Suspected hepatotoxicity by cimicifugae racemosae rhizoma (black cohosh, root): critical analysis and structured causality assessment. Phytomedicine 2009;16:72-84
   PubMed Web of Science ®Google Scholar
• Teschke R, Bahre R. Severe hepatotoxicity by Indian Ayurvedic herbal products: A structured causality assessment. Ann Hepatol 2009;8:258-66
   PubMed Web of Science ®Google Scholar
• García-Cortés M, Borraz Y, Lucena MI, Liver injury induced by “natural remedies”: an analysis of cases submitted to the Spanish Liver Toxicity Registry. Rev Esp Enferm Dig 2008;100:688-95; Article in Spanish
   PubMed Web of Science ®Google Scholar
• Teschke R, Bahre R, Fuchs J, Black cohosh hepatotoxicity: quantitative causality evaluation in nine suspected cases. Menopause 2009;16:956-65
   PubMed Web of Science ®Google Scholar
• Andrade RJ, Lucena MI, Fernández MC, Spanish Group for the Study of Drug-induced Liver Disease. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology 2005;129:512-21
   PubMed Web of Science ®Google Scholar
• Lucena MI, Camargo R, Andrade RJ, Comparison of two clinical scales for causality assessment in hepatotoxicity. Hepatology 2001;33:123-30
   PubMed Web of Science ®Google Scholar
• Aithal PG, Day CP. The natural history of histologically proved drug induced liver disease. Gut 1999;44:731-5
   PubMed Web of Science ®Google Scholar
• Aithal GP, Rawlins MD, Day CP. Accuracy of hepatic adverse drug reaction reporting in one English health region. Br Med J 1999;319:154
   Google Scholar
• Rochon J, Protiva P, Seeff LB, For the Drug-Induced Liver Injury Network (DILIN). Reliability of the Roussel Uclaf Causality Assessment Method for assessing causality in drug-induced liver injury. Hepatology 2008;48:1175-83
   PubMed Web of Science ®Google Scholar
• Dalton HR, Fellows HJ, Stableforth W, The role of hepatitis E virus testing in drug-induced liver injury. Aliment Pharmacol Ther 2007;26:1429-35
   PubMed Web of Science ®Google Scholar
• Davern TJ, Chalasani N, Fontana RJ, For the Drug-Induced Liver Injury Network (DILIN). Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury. Gastroenterology 2011;141:1665-72
   PubMed Web of Science ®Google Scholar
• Hung SK, Hillier S, Ernst E. Case reports of adverse effects of herbal medicinal products (HMPs): a quality assessment. Phytomedicine 2011;18:335-43
   PubMed Web of Science ®Google Scholar
• Kaplowitz N. Causality assessment versus guilt-by-association in drug hepatotoxicity. 2001;33:308-10
   Google Scholar
• WHO, World Health Organization. The use of the WHO-UMC system for standardised case causality assessment. WHO Collaborating Centre for International Drug Monitoring (Uppsala Monitoring Centre, UMC), Database 2000. Available from: http://who-umc.org/Graphics/24734.pdf [Accessed 3 September 2012]
   Google Scholar
• Naranjo CA, Busto U, Sellers EM, A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45
   PubMed Web of Science ®Google Scholar
• García-Cortés M, Stephens C, Lucena MI, on behalf of the Spanish Group for the Study of Drug-Induced Liver Disease. Causality assessment methods in drug induced liver injury: strengths and weaknesses. J Hepatol 2011;55:683-91
   PubMed Web of Science ®Google Scholar
• Teschke R, Wolff A. Regulatory causality evaluation methods applied in kava hepatotoxicity: are they appropriate? Regul Toxicol Pharmacol 2011;59:1-7
   PubMed Web of Science ®Google Scholar
• Tajiri K, Shimizu Y. Practical guideline for diagnosis and early management of drug-induced liver injury. World J Gastroenterol 2008;14:6774-85
   PubMed Web of Science ®Google Scholar
• Kramer MS. Assessing causality of adverse drug reactions: global introspection and its limitations. Drug Inf J 1986;20:433-7
   Google Scholar
• Teschke R, Frenzel C, Schulze J, Suspected herbal hepatotoxicity: the pharmacovigilance dilemma with disputed and obsolete evaluation methods. Regul Toxicol Pharmacol 2012;64:343-4
   Web of Science ®Google Scholar
• Stammschulte T, Gundert-Remy U. Letter to the Editor. Spontaneous reports of primarily suspected herbal hepatotoxicity by Pelargonium sidoides: was causality adequately ascertained? Regul Toxicol Pharmacol 2012;64:342
   PubMed Web of Science ®Google Scholar
• Teschke R, Eickhoff A, Wolff A, Herbal hepatotoxicity and WHO global introspection. Ann Hepatol 2013;12:11-21
   PubMed Web of Science ®Google Scholar
• Teschke R, Schulze J. Suspected herbal hepatotoxicity: requirements for appropriate causality assessment by the US Pharmacopeia. Drug Saf 2012;35:1091-7
   PubMed Web of Science ®Google Scholar
• Sarma DN, Barrett ML, Chavez ML, Safety of green tea extract: a systematic review by the US Pharmacopeia. Drug Saf 2008;31:469-84
   PubMed Web of Science ®Google Scholar
• Weinstein DH, Twaddell WS, Raufman JP, SlimQuick®-associated hepatotoxicity in a woman with alpha-1 antitrypsin heterozygosity. World J Hepatol 2012;4:154-7
   PubMedGoogle Scholar
• Inoue H, Yamazaki S, Shimizu M, Liver injury induced by the Japanese herbal drug kamishoyosan. Gastroenterol Hepatol 2011;7:692-5
   Google Scholar
• Nebraska judgement of 8. September 2006. Available from: http://ahpa.org/portals/0/pdfs/06_0908_Blackcohosh_NebraskaDistrictCt.pdf [Accessed 3 September 2012]
   Google Scholar